Endocrine · Nov 10, 2026

Circulating DKK3 is associated with insulin resistance and inflammatory cytokines across normal glucose tolerance, impaired glucose tolerance and type 2 diabetes mellitus: an exploratory cross-sectional study

By Wang Y, Sun X, Huang R et al.

Background Type 2 diabetes mellitus (T2DM) involves insulin resistance, inflammation, and hyperglycemia. Dickkopf-related protein 3 (DKK3) has been proposed as a metabolic biomarker, but its role in glucose homeostasis remains unclear. We thus investigated circulating DKK3 levels across normal glucose tolerance (NGT), impaired glucose tolerance (IGT), and T2DM, and its associations with adiposity, insulin resistance, and systemic inflammation. Methods In this cross-sectional study of 674 participants (221 NGT, 208 IGT, and 245 newly diagnosed T2DM), we measured anthropometric factors and metabolic parameters, as well as serum levels of DKK3, inflammatory cytokines, and adiponectin. The clinical significance of circulating DKK3 was evaluated through correlation analysis, multivariate regression, logistic regression, and receiver operating characteristic (ROC) curve analysis. Dynamic DKK3 responses during oral glucose tolerance testing (OGTT) were also assessed. Results Circulating DKK3 rose stepwise from NGT to IGT to T2DM. It correlated positively with adiposity indices (BMI and waist circumference), glycemic parameters (fasting and post-load glucose, HbA1c, fasting insulin, and HOMA-IR), lipid profiles (triglycerides and free fatty acids), and pro-inflammatory cytokines (TNF-α, IL-6, and IL-18), whereas it was negatively correlated with HDL cholesterol and adiponectin. Elevated circulating DKK3 remained independently associated with IGT and T2DM after confounder adjustment. Circulating DKK3 showed moderate apparent discrimination for IGT (AUC = 0.682) and high apparent discrimination for T2DM (AUC = 0.906) within this study cohort. As these estimates were derived and evaluated in the same cohort, they are exploratory and potentially optimistically biased. Prospective validation in independent external cohorts is therefore required before clinical translation. During OGTT, circulating DKK3 levels peaked at 30 min, with greater excursions in IGT and T2DM than in NGT. Conclusions In this exploratory cross-sectional study, circulating DKK3 was associated with progressive metabolic deterioration across NGT, IGT and T2DM, but these findings require prospective external validation and do not establish diagnostic, predictive or causal utility.

doi.org/10.1007/s12020-026-04851-wPubMed 43007500Biomarkers

AgingResearch.News